compounded semaglutide crackdown news november 2025 The growing availability of GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in comments⬇️ FDA Intensifies Crackdown on GLP-1

Glaucoma: now and beyond

The jump from 2mg to 4mg is where many people report the most noticeable GI effects

Hospitalization represents a critical opportunity to optimize medical therapy, address gaps in care, and establish a structured plan for post-discharge management

GLP-3 style medications, also called triple agonists, are being studied because they may activate GLP-1, GIP, and glucagon pathways

The absence of early side effects does not by itself mean a medication is failing, and noticeable nausea is not proof that a medication is "working better." What may feel different during the first week

Are GLP-1 medications available without a prescription